{"schema_version":"1","generated_at":"2026-10-31T08:55:52.587Z","data_as_of":null,"url":"https://www.findmykol.com/kol/irl-greenwell","json_url":"https://www.findmykol.com/kol/irl-greenwell/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"irl-greenwell","name":"Irl Greenwell","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Medical University of South Carolina","institution_url":"https://www.findmykol.com/institution/medical-university-of-south-carolina","city":"Charleston","state":"SC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1043573009","orcid":"0000-0003-2752-8078","openalex":"A5012121701"},"summary":"Irl Greenwell is an Oncology physician affiliated with Medical University of South Carolina. OpenAlex indexes 55 publications with 483 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":55,"cited_by_count":483,"h_index":10,"latest_activity_year":2025,"source":"works"},"prescribing":{"data_year":2023,"areas_total":5,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":32.8,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":32.8,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":28}]},{"area":"Metabolism & gastrointestinal","share_pct":31,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":20.3,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":22},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":10.8,"drugs":[{"name":"Ondansetron Hcl","share_pct":56},{"name":"Ondansetron Odt","share_pct":44}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":15.9,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":9.5,"drugs":[{"name":"Brukinsa","share_pct":50},{"name":"Calquence","share_pct":50}],"max_beneficiaries":null},{"class":"Leukocyte Growth Factor","setting":"prescribed","share_pct":6.5,"drugs":[{"name":"Udenyca","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025018527","status":"verified"},{"title":"151 | CLINICAL VALIDITY OF NONINVASIVE GENOTYPING OF MCL AT DIAGNOSIS FROM BLOOD PLASMA BY CIRCULATING TUMOR DNA PROFILING","year":2025,"journal":"Hematological Oncology","source_url":"https://doi.org/10.1002/hon.70093_151","status":"verified"},{"title":"IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypes","year":2024,"journal":"Clinical Immunology","source_url":"https://doi.org/10.1016/j.clim.2024.109922","status":"verified"},{"title":"Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.7006","status":"verified"},{"title":"Asparaginase Treatment Patterns, Toxicity, and Outcomes Among Patients with Extranodal NK/T-Cell Lymphoma: A North American Multicenter Retrospective Cohort Study","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-211424","status":"verified"}],"source":"works"},"similar":[{"name":"Tanya Turan","slug":"tanya-turan","institution":"Medical University of South Carolina","specialty":"Neurology","url":"https://www.findmykol.com/kol/tanya-turan","json_url":"https://www.findmykol.com/kol/tanya-turan/profile.json"},{"name":"Michael Zile","slug":"michael-zile","institution":"Medical University of South Carolina","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/michael-zile","json_url":"https://www.findmykol.com/kol/michael-zile/profile.json"},{"name":"Don Rockey","slug":"don-rockey","institution":"Medical University of South Carolina","specialty":"Hepatology","url":"https://www.findmykol.com/kol/don-rockey","json_url":"https://www.findmykol.com/kol/don-rockey/profile.json"},{"name":"Andrew Atz","slug":"andrew-atz","institution":"Medical University of South Carolina","specialty":"Pediatric Cardiology","url":"https://www.findmykol.com/kol/andrew-atz","json_url":"https://www.findmykol.com/kol/andrew-atz/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}